Stockreport

Akers Biosciences Announces Q2 and H1 2018 Earnings

AKERS BIOSCIENCES INC COMMON S  (AKER) 
US:NASDAQ Investor Relations: akersbio.com/investor-center
PDF THOROFARE, N.J., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health inf [Read more]